Cited by 603Diabetes Management and ResearchDiabetes Treatment and ManagementPeripheral Neuropathies and Disorders

The DOI matches its Crossref record.

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

The Diabetes Control and Complications Trial Research Group.·1995·Annals of Internal Medicine

DOI 10.7326/0003-4819-122-8-199504150-00001

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine whether intensive therapy designed to achieve glycemic levels as close to normal as possible prevents or slows the progression of neuropathy when compared with conventional therapy in patients with insulin-dependent diabetes mellitus in the Diabetes Control and Complications Trial. DESIGN: Multicenter, randomized, controlled clinical trial. SETTING: 29 U.S. and Canadian clinical centers. PARTICIPANTS: 1441 patients aged 13 to 39 years, of whom 726 had had insulin-dependent diabetes mellitus for 1 to 5 years and had no retinopathy at baseline (primary prevention cohort); 715 had had diabetes for 1 to 15 years and had minimal to moderate nonproliferative retinopathy at baseline (secondary intervention cohort). INTERVENTION: Intensive therapy with three or more daily insulin injections or continuous subcutaneous insulin infusion guided by four or more glucose tests per day compared with conventional therapy with one or two daily insulin injections. RESULTS: Intensive therapy reduced the development of confirmed clinical neuropathy (defined as a history or physical examination consistent with clinical neuropathy confirmed by either abnormal nerve conduction or autonomic nervous system testing) by 64% (95% CI, 45% to 76%) in the combined cohorts after 5 years of follow-up (5% of the intensive therapy group compared with 13% of the conventional therapy group). The prevalence of abnormal nerve conduction and abnormal autonomic nervous system function were reduced by 44% (CI, 34% to 53%) and 53% (CI, 24% to 70%), respectively (26% of the intensive treatment group developed abnormal nerve conduction compared with 46% of the conventional treatment group; 4% of the intensive treatment group had abnormal autonomic nervous system function compared with 9% of the conventional treatment group). Finally, nerve conduction velocities generally remained stable with intensive therapy but decreased significantly with conventional therapy. CONCLUSION: Intensive diabetes therapy markedly delays or prevents the development of clinically manifest diabetic polyneuropathy as confirmed by objective nerve function testing in patients with insulin-dependent diabetes mellitus.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-122-8-199504150-00001

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 501–600 of 603

Metabolic and Clinical Significance of Diabetes Mellitus Type 2; Implication for Rising Prevalence in Nigeria
Oghagbon, E. K. (2018) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/1i2.201855 · Cited by 1
Ipidacrine efficacy in diabetic polyneuropathy complex treatment: A review
Zinovyeva, O. E., Egorov, P. D., Penkina, A. I., & Guseinov, S. S. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.2.201554 · Cited by 1
Relationship Between Metabolic Control and Complications in Diabetes
GENUTH, S. M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_11 · Cited by 2
Role of protein kinase C inhibition in the development of diabetic microvascular complications
Skljarevski, V., Ferdinand, S. J., & Kles, K. A. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.321 · Cited by 1
Neuromuscular Manifestations of Acquired Metabolic, Endocrine, and Nutritional Disorders
Bassam, B. A., & Bertorini, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0372-6.00020-7 · Cited by 1
Does the blood glucose control have an effect on the success of the painful diabetic neuropathy treatment?
Jovanikić, O., Andjelic, G., Lepić, M., et al. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp160613367j · Cited by 1
Clinical study, management of diabetic foot and its complications
Dhanraj, M., Thanislas, P. D., Samidurai, M., et al. (2021) · International Surgery Journal · doi:10.18203/2349-2902.isj20212366 · Cited by 1
Diabetic Neuropathy
Tesfaye, S. H., & Wu, J. (2018) · Contemporary diabetes · doi:10.1007/978-3-319-89869-8_3 · Cited by 1
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_10 · Cited by 1
Metabolic and Clinical Significance of Diabetes Mellitus Type 2; Implication for Rising Prevalence in Nigeria
Oghagbon, E. K. (2018) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/jbrcp.55 · Cited by 1
Number Needed to Treat: Overview
Bender, R. (2017) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat04972.pub2 · Cited by 2
Papel de Atención Primaria en las complicaciones crónicas de la diabetes
Céspedes, M., & Almendra, M. Á. M. (2005) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(05)72926-9 · Cited by 1
Utilidad de la pregabalina en el tratamiento de la neuropatía diabética dolorosa
Carreño, E. B., & Pico, A. M. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71455-9 · Cited by 1
Gastrointentinal Manifestations of Systemic Diseases
Israeli, E., & Bernstein, C. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch124 · Cited by 1
Diabetes Mellitus, evaluación del perfil de riesgo y efecto de la intervención multifactorial en el primer nivel de atención.Preprint
Ortiz-Vilchis, C. M. (2022) · doi:10.31219/osf.io/f3hy9 · Cited by 1
Management of neuropathic pain
Boulton, A. J. M., & Vileikytė, L. (2011) · doi:10.1007/978-1-908517-16-6_4 · Cited by 1
Managing Type 2 Diabetes in the Elderly
(2002) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572170202800114 · Cited by 1
10.1016/b978-1-4160-2911-3.50034-0
(2000) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50034-0 · Cited by 1
Metabolic Origins of Neurotoxic 1-deoxySphingolipids in Type 2 DiabetesPreprint
Majcher, A., Bjorklund, P., Holfeld, A., Čináková, A., Zurcher, A., Malagola, E., Yusifov, E., Kakava, S., Robert, J., Härdfeldt, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650588 · Cited by 1
Erectile Dysfunction Assessment and Management in Primary Care Practice
Kuritzky, L., & Miner, M. M. (2005) · Humana Press eBooks · doi:10.1385/1-59259-871-4:149
Management of Neuropathic Pain
Boulton, A. J. M., & Vileikytė, L. (2011) · Springer eBooks · doi:10.1007/978-0-85729-488-3_4
Pharmakotherapie der sensomotorischen Neuropathie
Luft, D. (2008) · Der Diabetologe · doi:10.1007/s11428-008-0261-4
Introduction to Diabetic Neuropathies
Boulton, A. J. M., & Vileikytė, L. (2011) · Springer eBooks · doi:10.1007/978-0-85729-488-3_1
Peut-on espérer une régression de la neuropathie diabétique après transplantation d’îlots ? Résultats d’une étude expérimentale chez le rat
Borot, S. (2010) · Diabetologia Notes de lecture · doi:10.1007/s13116-010-0033-3
Diagnostic et traitement des douleurs neuropathiques périphériques en milieu spécialisé dans une démarche de prise en charge globale : recommandations d’un groupe d’experts pour les pays du Maghreb francophone
Nejmi, M., Marouan, F. F., Taibi, R. O., et al. (2012) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2011.10.002
Proliferative Diabetic Retinopathy: Current Treatment Strategies for Progression
Scheindlin, J. A. (2002) · Springer eBooks · doi:10.1007/978-94-010-0614-9_9
C-Peptide and Diabetic Neuropathy in Patients with Type 1 Diabetes
Ekberg, K., & Wahren, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-391-2_12
Р-LIPOIC ACID PREPARATIONS IN THE TREATMENT OF DIABETIC NEUROPATHY
Зиновьева, О. Е., & Zinovyeva, O. E. (2009) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2009-26
The male biological clock
Fisch, H. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139169349.008
Promoting Disposable Insulin Pumps to Patients with Diabetes: A Primary Care Perspective
Unger, J. (2016) · Endocrine Practice · doi:10.4158/ep161252.co
Vascular Disease in Diabetes Mellitus
Poon, M., & Rayfield, E. J. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_63
The effects of applied combined physical procedures and alpha lipoic acid in treatment of patients with distal sensomotor polyneuropathy
Grbovic, V. M. (2013) · doi:10.2298/kg20131220grbovic
Coronary Artery Function in Diabetes Mellitus
Afonso, L., & Carli, M. F. D. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_64
Vascular Changes and Diabetic Neuropathy
Malik, R. A., Tesfaye, S. H., & Ward, J. D. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-091-9_23
Diabetes and Angiogenesis
Golakoti, T., Venkateswarlu, S., & Subbaraju, G. V. (2007) · Nutraceutical science and technology · doi:10.1201/9781420015584.ch21
Hvidoere Study Group: What Can Be Learned from Observational Studies
de Beaufort, C. E., Cameron, F., Hoey, H., et al. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_5
Neuropathies chez les diabétiques
Lozeron, P. (2016) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(16)75572-2
Relationship between Serum hsCRP Level and Sural Nerve Conduction Study in Diabetic Neuropathy
박근영, 김태우, & 박주현 (2009) · Jouranl of Korean Association of EMG Electrodiagnostic Medicine · doi:10.18214/jkaem.2009.11.1.7
Peripheral Neuropathy in Patients with End-Stage Renal Disease
강석, 권희규, 편성범, et al. (2009) · Jouranl of Korean Association of EMG Electrodiagnostic Medicine · doi:10.18214/jkaem.2009.11.2.55
Reply to Drs. Sacco et al.
Allen, M. D., Doherty, T. J., Rice, C. L., & Kimpinski, K. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00330.2017
A study to assess the efficacy of metabolic control of diabetes in the development of neuropathy
Ali, M. M., & Kumar, E. A. (2017) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20173231
Characterising Corneal Nerve Migration Rates in Healthy and Diabetic Individuals with and without Neuropathy
Rashah, K. A. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.119155
Metabolic and Clinical Significance of Diabetes Mellitus Type 2; Implication for Rising Prevalence in Nigeria
Oghagbon, E. K. (2018) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/jbrcp.v1.i2.2018.55
A Diabetic Man with Hand Numbness and Fainting Spells
Bertorini, T. E. (2008) · Neuromuscular Case Studies · doi:10.1016/b978-0-7506-7332-7.50010-6
Vitamin B12 and Holotranscobalamin Levels in Diabetic Peripheral Neuropathy Patients
Mohammed, N., Madhavi, K., Chandran, P. A., & Jabeen, S. A. (2016) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0004
Painful diabetic polyneuropathy: from clinical guidelines to daily practice
Khramilin, V. N., Demidova, I. Y., & Завьялов, А. Н. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-4-52-60
Infected Neuropathic Foot: Investigation
Sedberry, S. D., Gazes, M. I., & Blume, P. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-17918-6_35
Insulin and Diabetic Peripheral Nerve Pathologies
Kelkar, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2417-2_13
Diabetes Mellitus
Boulton, A. J. M., & Malik, R. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00053-6
Diabetes Control, Long-Term Complications, and Large Vessel Disease
Nathan, D. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00051-4
New Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
Souza, K. L. V. D., Rassi, M. M. B., de Sá, D. A. R., Bussuan, R. M., Rodrigues, L. C. D. S., & Arbex, A. K. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.491
Cardiac autonomic neuropathy in children and adolescents with Type 1 diabetes mellitus: Prevalence and relation to duration and control of diabetes.
Khan, W. I., Arshad, M. S., Anjum, S., et al. (2020) · The Professional Medical Journal · doi:10.29309/tpmj/2020.27.10.4522
Clinical scenario
(2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00001-4.x
Diabetic Neuropathy
Tesfaye, S. H., & Wu, J. (2022) · doi:10.1093/med/9780198870197.003.0278
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-3
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-2
Diabetic Polyneuropathy
Tesfaye, S. H. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-791-0_3
EVALUACIÓN DEL PERFIL DE BIENESTAR Y CONTROL AMBULATORIO EN PACIENTES CON DIABETES MELLITUS TIPO 2 DEL PRIMER NIVEL DE ATENCIÓN EN LA UNIDAD DE MEDICINA FAMILIAR NO. 249, 2020Preprint
Ortiz-Vilchis, C. M. (2022) · doi:10.31237/osf.io/bvp2z
DELETE THIS A NEW VERSION IS AVAILABLEPreprint
Ortiz-Vilchis, C. M. (2022) · doi:10.31219/osf.io/msvfp
Ultrasonographic Evaluation of Ulnar Neuropathy Around the Elbow in Diabetes Mellitus
Kim, K. H., & Kim, D. H. (2022) · Journal of Electrodiagnosis and Neuromuscular Diseases · doi:10.18214/jend.2022.00010
Diabetic Neuropathy
Fabrizi, G. M., Nolano, M., Cavallaro, T., & Ferrari, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-29514-5_18
Glycemic Goals
Brillon, D. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_39
Diabetic Neuropathy
Tecilazich, F., Dinh, T. L., & Veves, A. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_4
Clinical Trials of α-Lipoic Acid in Diabetic Polyneuropathy and Cardiac Autonomic Neuropathy
Rosen, P., Tritschler, H. J., King, G. A., et al. (2000) · CRC Press eBooks · doi:10.1201/9781482277326-19
Glycemic Goals
Brillon, D. J. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_27
Introduction to diabetic neuropathies
Boulton, A. J. M., & Vileikytė, L. (2011) · doi:10.1007/978-1-908517-16-6_1
Neuropathies, Diabetic
Bril, V., Smith, A. G., & Perkins, B. A. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.00677-1
Autonomic viscero-visceral cardioneuropathy (literature review and own data)
(2021) · Experimental and Clinical Physiology and Biochemistry · doi:10.25040/ecpb2021.01-02.005
Neuropathie diabétique
Valensi, P. E., Banu, I., & Chiheb, S. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00015-4
Number Needed to Treat: Overview
Bender, R. (2014) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat04972
Dysfonction érectile
Brock, G. B., & Harper, W. R. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.038
Neuropathie
Bril, V., Perkins, B. A., & Toth, C. C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.028
Diabetic Neuropathy
Bilous, F. R., & Donnelly, R. (2010) · Wiley eBooks · doi:10.1002/9781444391374.ch17
Temel İstatistik ve Makale Yazımı
Yayla, M. E. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1915
DISTAL POLYNEUROPATHY IN TYPE 2 DIABETIC PATIENTS: PATHOGENETIC THERAPY BY BERLITION
Khyzhnyak, O., & Mykytyuk, M. (2012) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2012.2.06
Diabetic Neuropathy
Fabrizi, G. M., Nolano, M., Cavallaro, T., & Ferrari, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-06731-0_18
Evaluation of The Antidiabetic Properties of The Aqueous And Methanol Extracts of FICUS MUCUSO (Wild Figs)
George, D. G., Uwakwe, A. A., & Ikewuchi, J. C. (2023) · World Journal of Innovative Research · doi:10.31871/wjir.14.1.15
ESTIMATION OF PATIENTS’ STATE WITH TYPE 1 DIABETES IN GOMEL REGION
Русаленко, М. Г. (2007) · Health and Ecology Issues · doi:10.51523/2708-6011.2007-4-3-16
Significance of Skin Hydration
Han, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-9805-8_8
Drug discovery and development for fibromyalgia using practical biomarkers throughout the process from relevant animal models to patients
Nagakura, Y., Tozaki‐Saitoh, H., & Takeda, H. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2202908
Network pharmacology-based investigation of potential targets of Vitamin K2MK7 in treatment of diabetic neuropathyPreprint
Patel, S., Shirodkar, S. S., & Majumdar, A. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3115419/v1
Neuropathy
Navarro, X., & Kennedy, W. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_59
Construção de um classificador de risco para prevenção do pé diabético usando redes neurais artificiais
Ferreira, A. C. B. H. (2020) · doi:10.47749/t/unicamp.2020.1260694
Pathogenesis of Microvascular Complications
Flyvbjerg, A. (2024) · doi:10.1002/9781119697473.ch42
Exploring the relationship between orthostatic hypertension and diabetes mellitus: a literature review
ÖCAL, S. (2024) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1338395
Neuropatie nei diabetici
Lozeron, P. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)48980-0
Diabetes Mellitus, evaluación del perfil de riesgo y efecto de la intervención multifactorial en el primer nivel de atenciónPreprint
Ortiz-Vilchis, C. M. (2024) · doi:10.31219/osf.io/uqan9
A Global Public Health Issue: Diabetes Mellitus
Hisar, K. M. (2023) · doi:10.69860/nobel.9786053359111.1
Diabetic Polyneuropathy
Tesfaye, S. H. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-168-8_4
10.1016/s0246-0378(23)47134-5
(2000) · Time to knit · doi:10.1016/s0246-0378(23)47134-5
Neuropathy in Metformin-Treated Type 2 Diabetes
Vinik, A. I. (2015) · doi:10.2337/9781580405713.case95
Naturopathy and yoga-based interventions modify risk factors of peripheral neuropathy and improve nerve conduction among Type-2 Diabetes Mellitus patients
Somisetty, K. G., Shetty, G. B., Sujatha, K. J., & Shetty, P. (2025) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2025.101147
“DCC Trial adequately demonstrated that strict glycaemic control through intensive therapy might lower the incidence of diabetic neuropathy by up to 64% [23].”
Intensive glycaemic control prevented or delayed diabetic neuropathy
BMJ Publishing Group Ltd (1995) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.1995.1.9
Implications of the DCCT in the Management of Diabetic Neuropathy
Gelber, D. A., & Pfeifer, M. A. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_7
Diabetic retinal disease: A sensory neuropathy
Gardner, T. W., & Malik, R. A. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00001-x
30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes
Calligaro, L., Liew, G., Cho, Y. H., Allen, D. W., Pryke, A., Cusumano, J. M., Chan, A. K. F., Craig, M. E., & Donaghue, K. C. (2026) · Diabetes Care · doi:10.2337/dc26-0388
Risk factors for distal symmetric polyneuropathy in patients with type 2 diabetes mellitus: A retrospective study
Yang, L., Deng, R., & Chen, L. (2026) · Medicine · doi:10.1097/md.0000000000049467
“[9] In addition to hyperglycemia, a growing body of evidence shows that aging, prolonged diabetes duration, dyslipidemia, hypertension, obesity, and smoking independently increase the likelihood of DSPN. [10,11] Clinical studies have further supported the concept of “microvascular–neural…”
Artificial intelligence for detection, prediction, and severity classification of diabetic peripheral neuropathy: a systematic review
Ying, T. J., & Ang, G. Y. (2026) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-026-03676-x
“Other studies relied on physical examination and symptoms which are less sensitive, possibly under-estimating DPN prevalence [47, 51].”
Clinical management
Bruggeman, B. S., Jacobsen, L. M., Foster, T. P., & Winter, W. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21725-8.00005-6
Ayurvedic management of diabetic peripheral neuropathy assessed by vibrotherm (the neuropathy analyser): a case report
Skaria, R., & Marikutty, T. C. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20263563

Authors: The Diabetes Control and Complications Trial Research Group.
Corresponding author: The Diabetes Control and Complications Trial Research Group.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1995-04-15
Volume: 122
Issue: 8
Pages: 561-568
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-122-8-199504150-00001
OpenAlex: W4245107010
Cited by: 602
References: 0
Citations by year: 2026: 7 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 22 · 2021: 18 · 2020: 17 · 2019: 10 · 2018: 24 · 2017: 22 · 2016: 24 · 2015: 19 · 2014: 25 · 2013: 23 · 2012: 24
FWCI: 8.76
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords: intensive diabetes therapy, diabetic neuropathy, diabetic polyneuropathy, type 1 diabetes, glycemic control, insulin pump therapy, multiple daily insulin injections, nerve conduction velocity, autonomic dysfunction, neuropathy prevention, Diabetes Control and Complications Trial
MeSH terms: Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Follow-Up Studies, Humans, Infusion Pumps, Insulin Infusion Systems, Neural Conduction, Patient Compliance, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks